Join

Compare · CSQ vs HQH

CSQ vs HQH

Side-by-side comparison of Calamos Strategic Total Return (CSQ) and abrdn Healthcare Investors Shares of Beneficial Interest (HQH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CSQ and HQH operate in Finance Companies (Finance), so they compete in similar markets.
  • CSQ is the larger of the two at $3.26B, about 3.6x HQH ($899.1M).
  • HQH has been more active in the news (2 items in the past 4 weeks vs 1 for CSQ).
MetricCSQHQH
Company
Calamos Strategic Total Return
abrdn Healthcare Investors Shares of Beneficial Interest
Price
$20.50-1.01%
$18.93-1.10%
Market cap
$3.26B
$899.1M
1M return
-
-
1Y return
-
-
Industry
Finance Companies
Finance Companies
Exchange
NASDAQ
NYSE
IPO
2004
1987
News (4w)
1
2
Recent ratings
0
0
CSQ

Calamos Strategic Total Return

Calamos Strategic Total Return Fund is a closed ended balanced mutual fund launched by Calamos Investments LLC. The fund is managed by Calamos Advisors LLC. It invests in the public equity and fixed income markets of the United States. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in common and preferred stocks of companies across all market capitalizations, convertible securities, and high yield corporate bonds with an average credit rating of BB as rated by S&P. The fund employs both fundamental and quantitative analysis with a combination of bottom-up and top-down security picking approaches to create its portfolio. Calamos Strategic Total Return Fund was formed on December 31, 2003 and is domiciled in the United States.

HQH

abrdn Healthcare Investors Shares of Beneficial Interest

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Latest CSQ

Latest HQH